Canada’s Drug Agency Seeks Nominations for Expert and Advisory Committee Members
Read more about Canada’s Drug Agency Seeks Nominations for Expert and Advisory Committee Members
ICER, NICE, and Canada’s Drug Agency Convene the Health Economics Methods Advisory
Read more about ICER, NICE, and Canada’s Drug Agency Convene the Health Economics Methods Advisory
International collaboration provides new guidance on the use of surrogate endpoints in cost-effectiveness analysis
Read more about International collaboration provides new guidance on the use of surrogate endpoints in cost-effectiveness analysis
Featured Reports
Powering evidence-informed drug and health technology decisions for sustainable, world-class health care for all
We are experts at finding, interpreting, and assembling the best available information, and we know that evidence is the foundation of good decision-making.
A National Capital Region’s top employer
We are proud and excited to share that our organization has been named one of the National Capital Region's top employers for 2025.
Latest News
Upcoming Events
2025 Watch List: Artificial Intelligence
10th Annual Forum: Pathways to Access and Reimbursement
Canada’s Drug Agency recognizes the traditional territories, rights, and diversity of all First Nations, Inuit, and Métis communities across Canada. Indigenous Peoples have been, and continue to be, excluded from and harmed by Canada’s health care systems. In the spirit of reconciliation, we are committed to addressing these inequities alongside Indigenous communities.